IDx-DR can diagnose diabetic retinopathy, the most common cause of vision loss among the more than 30 million Americans living with diabetes
The benefit..... over 30 million patients wouldn’t need to wait for an eye specialist to be available to get a diagnosis...
There will always be a need for a specialist to check and be responsible when the diagnosis is wrong - but that specialist can be a technician that can check lots - creating other jobs
Now that the FDA has cleared IDx-DR, it might lead the way to a new slew of autonomous diagnostic tests and the trade-offs they bring. Such as Googles DeepMind which is using AI to spot eye disease.